Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s stock price hit a new 52-week high during trading on Monday . The company traded as high as C$3.78 and last traded at C$3.54, with a volume of 58690 shares changing hands. The stock had previously closed at C$3.50.
Medexus Pharmaceuticals Price Performance
The company has a 50-day moving average of C$3.04 and a 200 day moving average of C$2.87. The company has a market cap of C$114.99 million, a PE ratio of -178.00 and a beta of 0.42.
Medexus Pharmaceuticals Company Profile
Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.
Featured Articles
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
